Lyon, twice in one day that I am going to agree with your posts- to a point.
We should have the same tests performed on both the MS-dx group and the control group. And in my opinion, that needs to be a venography.
There has been a lot of critique on the technique of the tests involved (i.e. results can be manipulated- intentinally or not- based on speed of the dye insertion, position of patient, etc.; I won't get into whether or not I feel these arguements have merit). If EVERYONE gets the venography, and stenosis is still dominant in MS patients over the control group, then we should be in a position to validate not only the findings, but the testing technique itself.
I am not convinced that the Doppler-only technique, albeit non-invasive, is accurate enough to serve as the sole testing protocol. Even so, I find it impressive that Buffalo found more MS patients indicative of CCSVI than in the control group with the Doppler alone- a fact that eludes some.
Three veins angioplastied. One renewed life.